|
Adverse Effects
Citations 101-110 of 590 total displayed.
|
Past content
(since Mar 1998):
|
- Commentaries
Impairments in Endocannabinoid Signaling and Depressive Illness
- Matthew N. Hill; Boris B. Gorzalka
JAMA 2009; 301: 1165-1166.
[Extract]
[Full text]
[PDF]
- Medical News & Perspectives
Studies Linking Smoking-Cessation Drug With Suicide Risk Spark Concerns
- Bridget M. Kuehn
JAMA 2009; 301: 1007-1008.
[Extract]
[Full text]
[PDF]
- Letters
Treatment With Amiodarone to Prevent Atrial Fibrillation
- Madhavi Bollu; Ravi K. Bobba; Edward L. Arsura
JAMA 2009; 301: 1019-a-1020-a.
[Extract]
[Full text]
[PDF]
- Letters
Treatment With Amiodarone to Prevent Atrial Fibrillation
- Pasquale Santangeli; Antonio Dello Russo; Fulvio Bellocci
JAMA 2009; 301: 1019.
[Extract]
[Full text]
[PDF]
- Letters
Treatment With Amiodarone to Prevent Atrial Fibrillation—Reply
- Sheba Ahmed; Harry J. G. M. Crijns; Isabelle C. Van Gelder
JAMA 2009; 301: 1020.
[Extract]
[Full text]
[PDF]
- Letters
5- Reductase Inhibitors and Risk of Hip Fracture—Reply
- Steven J. Jacobsen; Jiaxiao M. Shi; Ronald K. Loo
JAMA 2009; 301: 935-a.
[Extract]
[Full text]
[PDF]
- Letters
5- Reductase Inhibitors and Risk of Hip Fracture
- Madhavi Bollu; Andres C. Marte-Grau; Ravi K. Bobba
JAMA 2009; 301: 935.
[Extract]
[Full text]
[PDF]
- Original Contributions
Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome
- P. Michael Ho; Thomas M. Maddox; Li Wang; Stephan D. Fihn; Robert L. Jesse; Eric D. Peterson; John S. Rumsfeld
JAMA 2009; 301: 937-944.
[Abstract]
[Full text]
[PDF]
[ JAMA Report Video ]
- Medical News & Perspectives
Amid Lingering Questions, FDA Reprieves LDL Cholesterol–Lowering Medication
- Mike Mitka
JAMA 2009; 301: 813-815.
[Extract]
[Full text]
[PDF]
- Health Agencies Update
Antipsychotic Risks
- Bridget M. Kuehn
JAMA 2009; 301: 817-b.
[Extract]
[Full text]
[PDF]
|
|
